Merrie Viscarra, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1530 N Randall Rd Ste 210, Elgin, IL 60123 Phone: 224-760-7322 Fax: 224-535-8252 |
Lynn Rae Mershon, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1990 Larkin Ave, Suite 3, Elgin, IL 60123 Phone: 847-289-5727 Fax: 847-888-5469 |
Susan Eileen Zuckerman, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1975 Lin Lor Ln, Suite 195, Elgin, IL 60123 Phone: 847-468-1511 Fax: 847-468-1555 |
Dr. Anthony Paul Lebario, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 431 Summit St, Elgin, IL 60120 Phone: 847-289-8822 |
Dr. Michelle Pamplona Tabao, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1975 Lin Lor Ln, Suite 195, Elgin, IL 60123 Phone: 847-468-1511 Fax: 847-468-1555 |
James H Cohn, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1990 Larkin Ave, Suite 3, Elgin, IL 60123 Phone: 847-289-5727 Fax: 847-888-5469 |
Gary Michael Yarkony, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1975 Lin Lor Ln, Suite 195, Elgin, IL 60123 Phone: 847-468-1511 |
Dr. Neil Kishor Patel, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1530 N Randall Rd Ste 210, Elgin, IL 60123 Phone: 224-760-7322 Fax: 224-535-8252 |
Laura Cohon Shaikh, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 77 N Airlite St, Elgin, IL 60123 Phone: 847-289-5727 Fax: 847-888-5469 |
Patrick Dolan, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1990 Larkin Ave Ste 3, Elgin, IL 60123 Phone: 847-289-5727 Fax: 847-888-5469 |
News Archive
GenekamBiotechnology AG, which developed the first test for Zika virus detection in January 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy.
Pregnant women who suffer from the high risk condition pre-eclampsia which leads to the death of hundreds of babies every year are putting the lives of their unborn children at significantly increased risk if they continue to smoke during pregnancy.
Peregrine Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.
Embryonic stem cells could provide a new way of testing drugs for dangerous side effects, according to a leading British researcher.
The Globe and Mail examines Ethiopia and Malawi's role in next month's G20 talks in Toronto, Canada. Canadian Prime Minister Stephen Harper has invited both countries to participate in the meeting, which could significantly affect Africa because it has become the "premier forum for confronting global economic problems and for co-ordinating solutions," according to the Globe and Mail.
› Verified 1 days ago